It significantly improves all semen parameters, including sperm motility, sperm morphology, sperm volume, and sperm count, compared to monitored lifestyle changes alone.
The unique and patented combination formulation shows a synergistic effect that outperforms high-dose single-substance therapy in improving semen parameters.
It significantly reduces DNA fragmentation and increases DNA integrity in sperm cells, which may help reduce the risk of miscarriage.
- Pregnancy rate is 41.3% in the PROFERTIL subgroup with DFI > 15%, compared to 22.9% in the control group.
- Pregnancy rate is 27.8% in the PROFERTIL group compared to 15.3% in the control group (total study population).
It also supports recovery of sperm quality after COVID-19 infection.
Its efficacy has been proven in 8 clinical studies involving more than 1,000 patients.